Advanced search
Publication Cover
Acta Oncologica Volume 31, 1992 - Issue 3
Journal homepage
95
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Weekly Oral Idarubicin in Advanced Prostatic Cancer A Phase II Study

Ebbe L. Madsen Department of Oncology R, Odense University Hospital, Odense, Denmark
,
Lars Bastholt Department of Oncology R, Odense University Hospital, Odense, Denmark
,
Kamma Bertelsen Department of Oncology R, Odense University Hospital, Odense, Denmark
,
Carsten Rose Department of Oncology R, Odense University Hospital, Odense, Denmark
,
Erik S. Nielsen Department of Oncology, Esbjerg Hospital, Esbjerg, Denmark
&
Carl C. Gadeberg Department of Oncology, Vejle Hospital, Vejle, Denmark
Pages 337-340 | Received 06 May 1991, Accepted 24 Sep 1991, Published online: 08 Jul 2009

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Willi Kreis. (1995) Current Chemotherapy and Future Directions in Research for the Treatment of Advanced Hormone-Refractory Prostate Cancer. Cancer Investigation 13:3, pages 296-312.
Read now

Articles from other publishers (4)

S. Schmid, A. Omlin, D. Blum, F. Strasser, S. Gillessen & C. Rothermundt. (2015) Assessment of anticancer-treatment outcome in patients with metastatic castration-resistant prostate cancer—going beyond PSA and imaging, a systematic literature review. Annals of Oncology 26:11, pages 2221-2247.
Crossref
Hans-Peter Schmid, Rudolf Maibach, Juerg Bernhard, Franz Hering, Silvia Hanselmann, Heidi Gusset, Rudolf Morant, Dietegen Pestalozzi & Monica Castiglione. (1997) A Phase II study of oral idarubicin as a treatment for metastatic hormone-refractory prostate carcinoma with special focus on prostate specific antigen doubling time. Cancer 79:9, pages 1703-1709.
Crossref
D. Raghavan, B. Koczwara & M. Javle. (1997) Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. European Journal of Cancer 33:4, pages 566-574.
Crossref
M. Goebel. (1993) Oral idarubicin — an anthracycline derivative with unique properties. Annals of Hematology 66:1, pages 33-43.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.